This event was previously reported to the fda on an alternative summary report (asr approval #: (b)(4) march 2016 submission) which is no longer in effect.Because of additionally received complaint information, this and all further updates will be submitted through the 3500a form.New info: information was also received indicating that the mesh involved in this incident is not a medtronic/covidien product.No further reports will be sent for this event.This was previously reported through an alternative summary report as a mesh sofradim - ugytex (procode ftl) mesh device.The actual device involved is a non-medtronic avaulta solo mesh device.If information is provided in the future, a supplemental report will be issued.
|
It was reported by the patient's attorney that as a result of having the product implanted, the patient has experienced injury, pain, disability and impairment.Product was used for therapeutic treatment.Per additional information received, the patient has experienced prolapse, incontinence, pelvic pain, bleeding, pain during sexual relations, depression, anxiety, pain, bleeding in vagina during sexual relations (intermenstrual bleeding), bowel obstruction, cystocele/rectocele (prolapse), hernias, hypotension/low blood pressure, anemia, recurrent vaginal pain, severe piercing cramps (cramp), pulling sensation (foreign body sensation), urinary incontinence, vaginal vault prolapse, failed mesh (failure of implant), and required nonsurgical interventions.
|